NNNN:NASDAQAnbio Biotechnology analysis

Anbio Biotechnology trades at $4.26, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Over a rolling month the price has lost 41.6%. Relative strength is 25.1 — oversold — and the MACD signal is bearish. Watch $3.88 as support and $6.95 as the nearer resistance level.
Valuation screens as overvalued: a P/E of 28.4 sits in line with the sector average of 30.3. Revenue is growing at 73.9% on a 74.1% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 78.4%, a beta of 0.26 and a maximum drawdown of 89.6%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.